Appetite (Eating) Disorders Market - Industry Analysis, Market Size, Share, Trends, Growth And Forecast 2022 - 2027

Report Code: HCR 0611 Report Format: PDF + Excel

Appetite (Eating) Disorders Market Overview

Appetite (Eating) Disorders Market Size is estimated to reach $682.4 million by 2027. Furthermore, it is poised to grow at a CAGR of 5.2% over the forecast period of 2022-2027. Appetite (Eating) Disorders are a type of unleavened dough that is rolled flat and sliced into long strips or strings before being expanded or extruded. Appetite disorders are mental health disorders that involve severe problems with thoughts about food and eating behaviors. There are various Appetite Disorders, such as Anorexia Nervosa, Bulimia Nervosa, Rumination Disorder, Binge Eating Disorder, Purging Disorder, Food Intake Disorder, and Others. The rise in the prevalence of anorexia nervosa and bulimia nervosa disorders, growing research and development activities to develop advanced treatments for appetite disorders, and the increase in the incidences of suicides owing to psychiatric illnesses are the major factors contributing to the growth of the Appetite (Eating) Disorders Market for the forecast period 2022-2027.

Appetite (Eating) Disorders Market Report Coverage

The report: “Appetite (Eating) Disorders Market Forecast (2022-2027)", by Industry ARC covers an in-depth analysis of the following segments of the Appetite (Eating) Disorders Market.

By Type: Anorexia Nervosa, Bulimia Nervosa, Rumination Disorder, Binge Eating Disorder, Purging Disorder, Food Intake Disorder, and Others.
By Route of Administration: Oral, Parenteral, and Others.
By End User: Hospitals, Specialty Clinics, and Others.
By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and the Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, Chile, Colombia, and Rest of South America), and Rest of the World (the Middle East, and Africa).

Key Takeaways

  • Geographically, North America held a dominant market share in the year 2021, owing to the trend of healthy food. The companies are offering innovative therapies for various eating disorders. A robust economy and a growing trend in in-home care facilities are driving demand for Appetite (Eating) Disorders Market in this region.
  • The increasing prevalence of psychiatric illnesses is driving the growth of the Appetite (Eating) Disorders Market. However, the lack of awareness about appetite disorders is expected to hinder the growth of the target market to a certain extent.
  • A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Appetite (Eating) Disorders Market Report.

Appetite (Eating) Disorders Market: Market Share (%) by Region, 2021

Appetite (Eating) Disorders Market

For more details on this report - Request for Sample

Appetite (Eating) Disorders Market Segmentation Analysis- By Type

Appetite (Eating) Disorders Market based on type can be further segmented into Anorexia Nervosa, Bulimia Nervosa, Rumination Disorder, Binge Eating Disorder, Purging Disorder, Food Intake Disorder, and Others. Anorexia Nervosa held a dominant market share in the year 2021. Anorexia nervosa is an eating disorder that results in severe weight loss and patients with anorexia nervosa are preoccupied with calorie intake and weight. The key players are focusing on developing a quality treatment for anorexia nervosa disorders.

However, Bulimia Nervosa is estimated to be the fastest-growing, with a CAGR of 5.8% over the forecast period of 2022-2027. This is owing to the growing prevalence of Bulimia Nervosa disorders and the rise in the availability of treatments for Bulimia Nervosa disorders in emerging countries.

Appetite (Eating) Disorders Market Segmentation Analysis- By End Use

Appetite (Eating) Disorders Market based on the End-Use can be further segmented into Hospitals, Specialty Clinics, and Others. The Hospitals segment held a dominant market share in the year 2021. The rise in the prevalence of psychiatric illnesses across the world and the growing availability of sophisticated professionals for treating eating disorders in hospitals are the major factors contributing to the growth of the Appetite (Eating) Disorders Market.

However, the Specialty Clinics segment is estimated to be the fastest-growing, with a CAGR of 6.2% over the forecast period of 2022-2027. Specialty clinics are providing outpatient clinic needs with cognitive-behavioral techniques that are specific for anorexia nervosa and bulimia nervosa disorders. As a result, the market for Appetite (Eating) Disorders is expected to grow throughout the forecast period. 

Appetite (Eating) Disorders Market Segmentation Analysis- By Geography

The Appetite (Eating) Disorders Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 34% in the year 2021. The rise in the prevalence of eating disorders is driving the growth of the market. Key manufacturers are leading the Appetite Disorders market in this region with innovative treatment developments and expansions.

Furthermore, Asia-Pacific is estimated to grow with the fastest CAGR over the forecast period 2022-2027. Consumers in this region have shown a willingness to spend more on their mental health. Some of the primary variables that are anticipated to enhance the demand for the Appetite (Eating) Disorders market in this region are the growing availability of sophisticated professionals and an increase in the number of suicides owing to mental disorders.

Appetite (Eating) Disorders Market Drivers

The Increasing Prevalence of Anorexia Nervosa is a Key Factor in Market Growth.

Around 1.1% to 4.2% of the female population in the United States have bulimia nervosa and 0.5% to 3.7% of the female population in the country are suffering from anorexia nervosa. Approximately 1 million men and 7 million women are suffering from appetite disorders. Women are more prone to anorexia nervosa disorders than men. The key players are focusing on developing nutritional and functional therapies for anorexia nervosa disorders, which is one of the major factors driving the growth of the Appetite (Eating) Disorders Market.

The Rise in Psychiatric Illnesses is Propelling the Market Growth.

According to the World Health Organization (WHO), around 20% of adolescents and children across the world have mental health conditions, with suicide the second leading cause of death among the population below 29 years old. Appetite disorders co-occur with other psychiatric disorders, such as obsessive-compulsive disorder, mood and anxiety disorders, and alcohol and drug abuse problems. This rise in the prevalence of psychiatric illnesses is further propelling the growth of the Appetite (Eating) Disorders Market.

Appetite (Eating) Disorders Market Challenges

Lack of Awareness about the Appetite Disorders is Hampering the Growth of the Appetite (Eating) Disorders Market.

According to the National Eating Disorders Association 2020 Statistics, 60% of the patients make a full recovery in the United States. However, only 1 in 10 people with an eating disorder are seeking and receiving treatment for their disorders. Moreover, less than 43.6% of the people with binge eating disorders are receiving treatment in the United States. This lack of awareness about appetite disorders is one of the major factors that is said to reduce the growth of the Appetite (Eating) Disorders Market.

Appetite (Eating) Disorders Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Appetite (Eating) Disorders Market. The top 10- Appetite (Eating) Disorders Market companies are-

  1.  Bausch & Lomb Incorporated
  2. Somerset Therapeutics, LLC
  3. Equip
  4. Teva Pharmaceuticals Industries Ltd
  5. Mylan N.V.
  6. Pfizer Inc.
  7. Amneal Pharmaceutical LLC
  8. Sun Pharmaceutical Industries Ltd
  9. Moriah Behavioral Health
  10. Eli Lilly and Company

Recent Developments

  • In April 2022, Moriah Behavioral Health opened its Dutch Valley home, which provides eating disorder treatment for adult females. It provides a comprehensive healthcare system for the treatment of anxiety disorders and eating disorders. The provides a full continuum of care for adolescent females struggling with eating disorders.
  • In October 2021, Within Health company launched the first comprehensive treatment solution that is designed specifically for people suffering from various eating disorders. These solutions are designed to interrupt the progression of eating disorders and support long-term recovery. These solutions are targeted to benefit patients from receiving intensive clinical care anytime and in their homes.
  • In October 2021, Equip company expanded into Colorado, Georgia, and Illinois. The expansion is targeted to ensure that every family has access to eating disorder treatment that works. The company has also closed a $13 million Series A funding round that is aimed at geographic expansion.

Relevant Titles

Report Code: HCR 0321

Report Code: HCR 0266

Report Code: HCR 58284 

For more Lifesciences and Healthcare related reports, please click here

1. Appetite (Eating) Disorders Market- Overview
    1.1 Definitions and Scope
2. Appetite (Eating) Disorders Market- Executive Summary
3. Appetite (Eating) Disorders Market- Comparative Analysis
    3.1 Company Benchmarking - Key Companies
    3.2 Global Financial Analysis - Key Companies
    3.3 Market Share Analysis - Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Appetite (Eating) Disorders Market- Start-up Companies Scenario Premium
    4.1 Key Start-up Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Appetite (Eating) Disorders Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Case Studies of Successful Ventures
6. Appetite (Eating) Disorders Market- Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Appetite (Eating) Disorders Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Appetite (Eating) Disorders Market – By Type
    8.1 Anorexia Nervosa
    8.2 Bulimia Nervosa
    8.3 Rumination Disorder
    8.4 Binge Eating Disorder
    8.5 Purging Disorder
    8.6 Food Intake Disorder
    8.7 Others
9. Appetite (Eating) Disorders Market – By Route of Administration
    9.1 Oral
    9.2 Parenteral
    9.3 Others
10. Appetite (Eating) Disorders Market – By End User
    10.1 Hospitals
    10.2 Specialty Clinics
    10.3 Others
11. Appetite (Eating) Disorders Market- By Geography
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Chile
        11.4.4 Colombia
        11.4.5 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Appetite (Eating) Disorders Market- Entropy
13. Appetite (Eating) Disorders Market – Industry/Segment Competition Landscape Premium 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
    13.2 Competition Matrix
    13.3 Best Practices for Companies
14. Appetite (Eating) Disorders Market – Key Company List by Country Premium Premium
15. Appetite (Eating) Disorders Market- Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.